Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Facchini

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|January 18, 2017
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatinA Bergamini, C Pisano, M Di Napoli, et al.
Thyroid : Official Journal of the American Thyroid Association|December 17, 2002
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large seriesS Del Prete, M Caraglia, D Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancerR V Iaffaioli, A Tortoriello, G Facchini, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2007
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE)G Facchini, M Caraglia, D Santini, et al.
Current Medicinal Chemistry|January 2, 2013
Deregulation of HOX B13 expression in urinary bladder cancer progressionL Marra, M Cantile, G Scognamiglio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2001
Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancerR V Iaffaioli, A Tortoriello, A Gravina, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2017
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysisR Di Franco, V Borzillo, V Ravo, et al.
Current Cancer Drug Targets|April 3, 2012
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancerC D' Alterio, L Portella, A Ottaiano, et al.
European Review for Medical and Pharmacological Sciences|December 4, 2020
Advanced/metastatic bladder cancer: current status and future directionsG Facchini, C Cavaliere, L Romis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancersE Strocchi, R V Iaffaioli, G Facchini, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|January 18, 2017
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatinA Bergamini, C Pisano, M Di Napoli, et al.
Thyroid : Official Journal of the American Thyroid Association|December 17, 2002
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large seriesS Del Prete, M Caraglia, D Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancerR V Iaffaioli, A Tortoriello, G Facchini, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2007
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE)G Facchini, M Caraglia, D Santini, et al.
Current Medicinal Chemistry|January 2, 2013
Deregulation of HOX B13 expression in urinary bladder cancer progressionL Marra, M Cantile, G Scognamiglio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2001
Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancerR V Iaffaioli, A Tortoriello, A Gravina, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2017
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysisR Di Franco, V Borzillo, V Ravo, et al.
Current Cancer Drug Targets|April 3, 2012
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancerC D' Alterio, L Portella, A Ottaiano, et al.
European Review for Medical and Pharmacological Sciences|December 4, 2020
Advanced/metastatic bladder cancer: current status and future directionsG Facchini, C Cavaliere, L Romis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancersE Strocchi, R V Iaffaioli, G Facchini, et al.
Pageof 9